Ascentage Pharma Group International (AAPG) Other Non-Current Liabilities (2024 - 2025)

Ascentage Pharma Group International's Other Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $1.7 million for Q4 2025.

• In Q4 2025, Other Non-Current Liabilities rose 94.21% year-over-year to $1.7 million; the TTM figure through Dec 2025 stood at $1.7 million (up 94.21% YoY), while the FY2025 annual figure was $1.7 million, up 100.0% from the prior year.
• Other Non-Current Liabilities for Q4 2025 stood at $1.7 million, up from $873439.4 in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $2.5 million in Q4 2023, with the low at $873439.4 in Q4 2024.
• The 3-year median for Other Non-Current Liabilities is $1.7 million (2025), against an average of $1.7 million.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities slumped 65.63% in 2024, then surged 94.21% in 2025.
• Ascentage Pharma Group International's Other Non-Current Liabilities stood at $2.5 million in 2023, then plunged by 65.63% to $873439.4 in 2024, then soared by 94.21% to $1.7 million in 2025.
• Business Quant data shows AAPG's Other Non-Current Liabilities at $1.7 million in Q4 2025, $873439.4 in Q4 2024, and $2.5 million in Q4 2023.